Wird geladen...

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients

INTRODUCTION: By targeting different subtypes of 5-hydroxytryptamine (5HT) receptors in the gastrointestinal (GI) tract, several drugs have been introduced for the management of irritable bowel syndrome (IBS). Renzapride is a full agonist for 5HT4 receptor and an antagonist to 5HT2b and 5HT3 recepto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad
Format: Artigo
Sprache:Inglês
Veröffentlicht: Termedia Publishing House 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3953973/
https://ncbi.nlm.nih.gov/pubmed/24701208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2014.40729
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!